Indaptus Therapeutics
INDP
INDP
15 hedge funds and large institutions have $1.31M invested in Indaptus Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
81% less capital invested
Capital invested by funds: $6.81M → $1.31M (-$5.51M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$51K | |
| 2 | +$12.4K | |
| 3 | +$7K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$157K | |
| 3 | -$60K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 5 |
Morgan Stanley
New York
|
-$53 |